Where does Gencell Biosystems Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gencell Biosystems Ltd. ranks #22,631 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gencell Biosystems Ltd. hold?

Gencell Biosystems Ltd. holds 12 US utility patents granted between 2015 and 2020, spanning 9 technology areas.

What is Gencell Biosystems Ltd.'s Innovation Score?

Gencell Biosystems Ltd. has an Innovation Score of 28.8 out of 100 (28th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Gencell Biosystems Ltd. focus on?

Gencell Biosystems Ltd.'s top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 11 patents, ranking #169 of 1,325 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Gencell Biosystems Ltd.'s patent grant rate increasing or decreasing?

Gencell Biosystems Ltd.'s recent grant velocity is -91% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Gencell Biosystems Ltd.'s patents?

Gencell Biosystems Ltd.'s patents average 15.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gencell Biosystems Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Gencell Biosystems Ltd.

USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gencell ranks #22,631 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.

#22,631
of 49,997 US assignees by volume: 28th percentile
by Innovation Score (28.8/100): 15.5
avg claims per patent: -91%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22631 · Foreign Corporation #22,631 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,631/49,997
PHOTO-FINISH GE Medical Systems…
CPC-NARROW B01L · 9 areas
INNOV-THIN 28.8/100
CLAIMS-RICH 15.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -91% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: GE Medical Systems Israel, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gencell’s 28.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (31%) Velocity 0.0 pts (0%) Breadth 10.6 pts (37%) Claim depth 9.3 pts (32%)

Qualcomm Incorporated · highest

85
Gencell Biosystems · this assignee

29
3D Lighting… · lowest

7

What this shows Gencell's Innovation Score is 28.8/100 (28th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Gencell?

Each dot is one of Gencell’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gencell’s own 15.5 claims/patent is ABOVE the 12.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Gencell vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gencell's grants concentrate

Gencell Biosystems Ltd. is a focused PatentsView assignee: 9 CPC subclasses with 91.7% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2015. By volume, Gencell sits between GE Medical Systems Israel, Ltd. and GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN Stiftung ÖFFENTLICHEN Rechts.

GE Medical System…

12
GEA Food Solution…

12
GEA TDS

12
Gebr Brasseler &…

12
General Packer

12
GEO Semiconductor

12
Georg Menshen & KG

12
Georg-august-univ…

12
Gencell Biosystems ◀

12

What this shows Gencell holds 12 patents at rank #22,624, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gencell

By rank, the assignees closest to #22,624 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Gencell's primary technology class.

Gencell's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 28th percentile higher than 28% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Gencell Biosystems Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	8.3%
2016	1	8.3%
2017	2	16.7%
2018	3	25.0%
2019	4	33.3%
2020	1	8.3%

Which technologies does Gencell Biosystems Ltd. patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 11

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 5

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

Y10T - Technical Subjects Covered BY Former US Classification 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Gencell Biosystems Ltd.'s patent record in context - here's where to go next.

Gencell Biosystems Ltd.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 91.7% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #22,631 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gencell Biosystems Ltd. against GE Medical Systems Israel, Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.